SilverCrest Metals
SILV
Cars.com
CARS
Lantheus
LNTH
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
(Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 193.98%4.75M | -76.00%1.65M | -134.06%-1.82M | 93.99%18.49M | 331.01%11.33M | -288.93%-5.05M | 207.19%6.88M | 167.91%5.33M | -8.60%9.53M | 3.30%2.63M |
Net income from continuing operations | -9.93%3.04M | 15.67%2.24M | 12.05%2.44M | 50.73%10.17M | 9.00%2.69M | 87.71%3.38M | 49.46%1.93M | 82.69%2.17M | -15.16%6.75M | 57.77%2.47M |
Operating gains losses | 149.32%181K | 221.84%106K | 95.31%-6K | -1.84%-663K | -149.09%-81K | -102.76%-367K | 84.38%-87K | -64.10%-128K | -848.28%-651K | -38.89%165K |
Depreciation and amortization | -7.38%439K | 0.00%445K | -1.34%442K | 1.05%1.82M | 2.48%455K | 6.04%474K | -3.68%445K | -0.44%448K | 1.92%1.8M | -4.93%444K |
Other non cashItems | 103.08%7K | -10.08%116K | 205.31%345K | -86.36%-123K | 54.00%-138K | ---227K | --129K | 2,160.00%113K | -13.79%-66K | -361.54%-300K |
Change in working capital | 106.50%513K | -155.78%-2.12M | -313.60%-5.45M | 429.20%6.11M | 3,393.53%7.64M | -1,286.82%-7.89M | 1,369.33%3.81M | 438.01%2.55M | -121.48%-1.86M | 38.13%-232K |
-Change in receivables | 33.99%-134K | 428.57%407K | 44.55%-239K | 104.64%55K | 37.53%612K | 74.04%-203K | 113.10%77K | -65.13%-431K | -3,853.33%-1.19M | 188.96%445K |
-Change in prepaid assets | 957.89%804K | 1,364.44%569K | 108.13%26K | -0.17%-591K | 29.44%-302K | 123.53%76K | 67.15%-45K | -442.37%-320K | -451.40%-590K | -63.98%-428K |
-Change in payables and accrued expense | 99.75%-19K | -175.57%-2.94M | -250.06%-5.1M | 673.38%7.15M | 1,571.78%7.52M | -2,888.36%-7.67M | 620.93%3.89M | 1,096.48%3.4M | 321.58%924K | 251.52%450K |
-Change in deferred charges | ---- | ---- | ---- | 89.22%-65K | ---- | ---- | ---- | ---- | -594.26%-603K | ---- |
-Change in other working capital | -43.75%-138K | -35.04%-158K | -46.32%-139K | -8.48%-435K | -32.29%-127K | 0.00%-96K | -1.74%-117K | -1.06%-95K | 1.23%-401K | -3.23%-96K |
Cash from discontinued operating activities | ||||||||||
Operating cash flow | 193.98%4.75M | -76.00%1.65M | -134.06%-1.82M | 93.99%18.49M | 331.01%11.33M | -288.93%-5.05M | 207.19%6.88M | 167.91%5.33M | -8.60%9.53M | 3.30%2.63M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -18.17%7.54M | 99.63%-171K | 37.95%-10.33M | 37.79%-58.26M | -122.17%-4.37M | 125.17%9.21M | -7.82%-46.46M | 50.57%-16.64M | -689.45%-93.65M | 300.35%19.7M |
Proceeds payment in interest bearing deposits in bank | 199.20%1.49M | ---- | ---- | -18.74%3.23M | -28.24%498K | 896.00%498K | ---- | ---- | 234.46%3.98M | 38.80%694K |
Net investment purchase and sale | 222.67%6.22M | 112.12%4.89M | 115.35%4.84M | -836.72%-76.38M | 104.40%559K | 38.85%-5.07M | -267.13%-40.35M | -537.06%-31.52M | 149.91%10.37M | -340.60%-12.7M |
Net proceeds payment for loan | -98.04%264K | 34.75%-6.02M | -201.99%-15.16M | 118.63%20.13M | -96.67%1.04M | 147.16%13.45M | 86.86%-9.22M | 136.62%14.86M | -1,018.91%-108.05M | 512.66%31.23M |
Net PPE purchase and sale | -201.05%-96K | -106.01%-58K | 26.97%-176K | 156.07%425K | -5,528.57%-394K | 152.78%95K | 472.59%965K | 22.76%-241K | 51.35%-758K | 97.79%-7K |
Net other investing changes | -240.83%-338K | 120.43%19K | -35.88%168K | -798.27%-5.66M | -1,362.37%-6.07M | -28.36%240K | -112.64%-93K | 135.36%262K | -51.44%811K | 11.09%481K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -18.17%7.54M | 99.63%-171K | 37.95%-10.33M | 37.79%-58.26M | -122.17%-4.37M | 125.17%9.21M | -7.82%-46.46M | 50.57%-16.64M | -689.45%-93.65M | 300.35%19.7M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 21.76%-13M | -98.06%625K | -60.32%12.61M | -89.30%11.41M | -428.91%-35.95M | -155.39%-16.61M | -43.14%32.18M | 18.69%31.78M | 1,849.99%106.57M | 74.85%-6.8M |
Increase decrease in deposit | -1.08%-10.91M | -95.09%1.63M | -46.44%17.46M | -76.65%24.87M | -409.88%-30.03M | -135.05%-10.8M | -61.52%33.09M | 839.56%32.6M | 316.39%106.5M | 71.82%-5.89M |
Net issuance payments of debt | 160.00%3M | ---50K | ---4M | -385.71%-10M | ---5M | ---5M | --0 | --0 | 120.83%3.5M | --0 |
Cash dividends paid | -7.59%-879K | -4.28%-950K | -3.92%-848K | -0.76%-3.46M | -1.21%-918K | -0.49%-817K | -0.77%-911K | -0.49%-816K | -3.71%-3.44M | -3.78%-907K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 21.76%-13M | -98.06%625K | -60.32%12.61M | -89.30%11.41M | -428.91%-35.95M | -155.39%-16.61M | -43.14%32.18M | 18.69%31.78M | 1,849.99%106.57M | 74.85%-6.8M |
Net cash flow | ||||||||||
Beginning cash position | -76.93%11.65M | -83.51%9.55M | -75.75%9.08M | 149.83%37.44M | 73.79%38.07M | 95.55%50.52M | 474.05%57.92M | 149.83%37.44M | 36.80%14.99M | -55.57%21.9M |
Current changes in cash | 94.26%-715K | 128.45%2.11M | -97.71%469K | -226.30%-28.36M | -286.57%-28.99M | -216.76%-12.45M | -146.99%-7.4M | 518.15%20.48M | 457.01%22.45M | 145.27%15.54M |
End cash position | -71.26%10.94M | -76.93%11.65M | -83.51%9.55M | -75.75%9.08M | -75.75%9.08M | 73.79%38.07M | 95.55%50.52M | 474.05%57.92M | 149.83%37.44M | 149.83%37.44M |
Free cash flow | 188.05%4.65M | -76.82%1.59M | -139.13%-1.99M | 110.33%17.62M | 391.59%10.93M | -311.83%-5.28M | 247.07%6.87M | 203.34%5.09M | -2.82%8.38M | -0.13%2.22M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |